25 results for “drug delivery”. Showing 25 of 39,449.
Nanobiotechnology-based drug delivery in brain targeting.
drug delivery systems to deliver the drug across the BBB. Nanoparticles
Nanoscale drug delivery systems and the blood-brain barrier.
drug delivery to the CNS. This makes it difficult to deliver
Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer's disease treatment.
drug delivery. This delivery system substantially attenuated H2O2- and scopolamine
The blood-brain barrier: structure, regulation, and drug delivery.
drug delivery into the brain leads to low therapeutic efficacy
Epigenetic Alterations in Alzheimer's Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems.
drug delivery systems for the targeted delivery of epigenetic drugs
Nanoparticles hijack calvarial immune cells for CNS drug delivery and stroke therapy.
drug delivery barriers in central nervous system (CNS) disorders. Here
Exosomes based strategies for brain drug delivery.
drug delivery, higher biocompatibility, facile traversing of physiological barriers, and subtle
Intranasal and inhaled delivery systems for targeting circadian dysfunction in neurodegenerative disorders, perspective and future outlook.
drug delivery formulations to improve drug absorption and target circadian
Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
drug delivery into target cells is essential to effectively elicit
Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model.
drug penetration across a variably permeable blood-brain barrier and diffusion across intratumoral compartments, more uniform delivery
Translating diagnostics and drug delivery technologies to low-resource settings.
drug delivery technologies engineered for low-resource settings aim to meet
Synthesis and evaluation of nanosized aluminum MOF encapsulating Umbelliferon: assessing antioxidant, anti-inflammatory, and wound healing potential in an earthworm model.
drug delivery of Umbelliferon (Um). The encapsulated Um was gradually
Mesoporous silica nanoparticle-supported nanocarriers with enhanced drug loading, encapsulation stability, and targeting efficiency.
drug delivery, stable encapsulation of a large amount of anticancer
FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems.
drug delivery systems can enhance the clinical therapeutic efficacy of these
Unstructured polypeptides as a versatile drug delivery technology.
drug delivery, the immunogenicity and non-biodegradability of this synthetic
Development of Injectable Thermosensitive Nanocomposite Hydrogel for Ratiometric Drug Delivery to Treat Drug Resistant Chondrosarcoma In Vivo.
drug delivery hydrogel platform. The platform utilizes "PLGA-PEG-PLGA
Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?
delivery of a great variety of drugs including anticancer drugs
The Nasal-Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases.
drug delivery (NBDD) route has emerged as a promising strategy
Transport mechanisms for cationic drugs and proteins in kidney, liver and intestine: implication for drug interactions and cell-specific drug delivery.
drug delivery. Meijer DK(1), Hooiveld GJ, Schinkel AH, van Montfoort
Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery.
drug delivery to the brain is the use of engineered
The Blood–Brain Barrier and CNS Drug Delivery
targeted for CNS drug delivery. An understanding of the comp
Dual-targeting of brain tumors with nanovesicles.
drug delivery that EPR effect may not be sufficient for successful
Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening.
drugs is the discovery and design of molecules that can cross the blood-brain barrier (BBB). Nano-delivery
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
delivery of conventional chemotherapeutics and novel therapeutics showing actual tumor concentrations and biologic effect are lacking. In this article, we review drug
Targeting the blood-brain barrier for the delivery of stroke therapies.
drug delivery both across the BBB and to the BBB as a viable